Our studies revealed a tumor suppressive role of Suv39h1 in MLL-r AML that is partially mediated by inactivation of Hoxb13 and Six1, as well as reversion of Hoxa9/Meis1 downstream transcriptomes. The gene discussed is KMT2A; the disease is acute myeloid leukemia.